Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Potent and selective VR1 antagonist described in recent abstract

Sep. 10, 2002

Syk inhibitors synthesized at Novartis as novel therapeutics for asthma

Sep. 10, 2002

CSP-2503: a potent and selective 5-HT1A agonist with anxiolytic activity

Sep. 10, 2002

Sigma-Tau synthesizes phenylalkylcarboxylates with superior profile to rosiglitazone

Sep. 10, 2002

Orally active B-cell IgE synthesis inhibitors discovered by Novartis team

Sep. 10, 2002

Clinical pharmacokinetic and safety data reported for insulin detemir

Sep. 10, 2002

New data support single daily doses of LY-307161 SR to treat type 2 diabetes

Sep. 10, 2002

Bupropion reported to enhance weight loss in dieting patients with depressive symptoms

Sep. 10, 2002

Weight-lowering effects of anticonvulsants

Sep. 10, 2002

Combining A-200, ephedrine and caffeine does not enhance weight loss in obese patients

Sep. 10, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...